Life Science Compliance Update

August

2016

August 2016: Life Science Compliance Update

Written by , Posted in August 2016 LSC Update, This Month in Compliance

The full text of this issue is now available to our subscribers. If you are a subscriber please log in now. You may also buy this issue by clicking on the button below.


   or   

August 2016 LSCU Cover

Issue Summary

August is transparency season, and appropriately this month we focus our attention not only the recent Open Payments data release, thanks to an excellent article from Huron Life Sciences, but also some global numbers out of Germany and the UK. The team at Attest Open-Payments has taken a look at the 2015 Open Payments data set and noted some challenges with the data quality. Chris Cobourn, also from Huron, continues his series on AMP, and of course, no Update issue would be complete without the usual enforcement case roundup.


Feature Article

Arrow

Tis The Season – 2015 Open Payments Highlights and Risk Management Considerations
Mark Linver, Jeff Fisher, Juan Tessi of Huron Life Sciences
Abstract


Issue Articles

Arrow

Caveat User, Caveat Emptor – Issues from the Soft Under Belly of The CMS Data Sets
Mark Labovitz, Ph.D., MS, MBA, Principal, Attest Open-Payments™ and President, Data Analysis Consulting (DAC), LLC.
Abstract

Arrow

Transparency Across the Pond – A Look at Efforts in Germany and the UK
Kaitlin Fallon Wildoner, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

What You Don’t Know About AMP Can Hurt You – Part 2 This is Not Your Father’s AMP
Chris Cobourn, Managing Director, Huron Life Sciences
Abstract

Arrow

Weighing in on the Recent Acquittals – Former HHS Inspector General Offers Practical Suggestions for Compliance Officers
Matthew Hay, Guest Contributor, Life Science Compliance Update
Abstract

Arrow

A Mixed Bag – Implied Certification in False Claim Act Cases after the Escobar Decision
Robert N. Wilkey, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

Railroad Retirement Board (RRB) First to Double-Down on DOJ’s Civil Penalties for FCA Violations
Robert N. Wilkey, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

Misleading Survival Data Leads to FCA Liability in Recent Genentech Case
Kaitlin Fallon Wildoner, Esq., Staff Writer for Life Science Compliance Update
Abstract

Gravityscan Badge
Menu Title